Cargando…
Oseltamivir resistance in swine influenza: a brief discussion
Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treat...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364646/ https://www.ncbi.nlm.nih.gov/pubmed/22666678 |
_version_ | 1782234572781518848 |
---|---|
author | Wiwanitkit, Viroj |
author_facet | Wiwanitkit, Viroj |
author_sort | Wiwanitkit, Viroj |
collection | PubMed |
description | Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treatment of classical H1NI influenza virus infection is drug resistance. In this brief paper, the author discusses on the situation of oseltamivir resistance in swine influenza. Briefly, the oseltamivir resistance of swine flu is expected to be possible due to many underlying factors. It is needed to perform surveillance on oseltamivir resistance in swine flu. Planning for management of case of emerging oseltamivir drug resistance is needed. |
format | Online Article Text |
id | pubmed-3364646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-33646462012-06-04 Oseltamivir resistance in swine influenza: a brief discussion Wiwanitkit, Viroj N Am J Med Sci Invited Article Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treatment of classical H1NI influenza virus infection is drug resistance. In this brief paper, the author discusses on the situation of oseltamivir resistance in swine influenza. Briefly, the oseltamivir resistance of swine flu is expected to be possible due to many underlying factors. It is needed to perform surveillance on oseltamivir resistance in swine flu. Planning for management of case of emerging oseltamivir drug resistance is needed. Medknow Publications & Media Pvt Ltd 2009-08 /pmc/articles/PMC3364646/ /pubmed/22666678 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Article Wiwanitkit, Viroj Oseltamivir resistance in swine influenza: a brief discussion |
title | Oseltamivir resistance in swine influenza: a brief discussion |
title_full | Oseltamivir resistance in swine influenza: a brief discussion |
title_fullStr | Oseltamivir resistance in swine influenza: a brief discussion |
title_full_unstemmed | Oseltamivir resistance in swine influenza: a brief discussion |
title_short | Oseltamivir resistance in swine influenza: a brief discussion |
title_sort | oseltamivir resistance in swine influenza: a brief discussion |
topic | Invited Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364646/ https://www.ncbi.nlm.nih.gov/pubmed/22666678 |
work_keys_str_mv | AT wiwanitkitviroj oseltamivirresistanceinswineinfluenzaabriefdiscussion |